Innovations in Addressing Disparities in Cancer

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 1515

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Microbiology, Immunology and Biochemistry, Morehouse School of Medicine, Atlanta, GA 30310, USA
2. Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA
Interests: targeted therapy; nano-therapy; nano-delivery; chemokine; combination therapy; prostate cancer; pancreatic cancer; liver cancer; ovarian cancer; breast cancer
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Department of Microbiology, Immunology, and Biochemistry, Morehouse School of Medicine, Atlanta, GA 30310, USA
2. Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA
Interests: cancer progression and metastasis; tumor immunobiology; cancer health disparity
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Despite significant progress in cancer prevention, diagnosis, and treatment, disparities in cancer care remain a pressing challenge. Health, recognized as a fundamental human right by the World Health Organization (WHO), should be accessible to all, regardless of background, emphasizing the importance of achieving the highest health standards for all, regardless of background. This Special Issue aims to promote innovation in cancer research to expand possibilities in cancer prevention, early detection, diagnosis, treatment, and patient-centered care. As the financial burden of noncommunicable diseases, particularly cancer, continues to grow, it is essential for health authorities globally to evaluate and adopt the most impactful technologies, policies, and practices. We invite submission on topics such as digital health innovations: enhancing collaboration among multidisciplinary teams; advanced molecular diagnostics: improving pathology services; counseling apps: addressing the psychological effects of HPV testing; and genomic approaches: reducing cancer disparities and promoting health equity.

This Special Issue will feature original research, reviews, and editorials across basic, translational, and clinical studies focused on disparities in all cancer types. Area of interest includes artificial intelligence and machine learning: application in cancer care; social determinants of health (SDOH): their role in cancer disparities; and health informatics and data science: leveraging technology to address disparities, the molecular underpinnings of these disparities, race-related differences in tumor immunity, transcriptomic studies on cancer disparities, and the socioeconomic status (SES) associations with cancer's cellular and molecular signatures that affect disease progression and treatment responses.

We look forward to receiving your contributions.

Prof. Dr. Rajesh Singh
Prof. Dr. Shailesh Singh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • artificial intelligence on health equity
  • artificial intelligence and machine learning technologies in cancer care
  • genomic testing and biomarkers
  • AI in social determinants of health
  • health justice
  • precision medicine and health informatics
  • innovative cancer care delivery model for overcoming health disparity
  • equity lens
  • racial differences in the immunological landscape
  • racial differences in treatment and disease outcome

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

23 pages, 1540 KB  
Review
Revolutionizing Oncology Through AI: Addressing Cancer Disparities by Improving Screening, Treatment, and Survival Outcomes via Integration of Social Determinants of Health
by Amit Kumar Srivastav, Aryan Singh, Shailesh Singh, Brian Rivers, James W. Lillard, Jr. and Rajesh Singh
Cancers 2025, 17(17), 2866; https://doi.org/10.3390/cancers17172866 - 31 Aug 2025
Viewed by 964
Abstract
Background: Social determinants of health (SDOH) are critical contributors to cancer disparities, influencing prevention, early detection, treatment access, and survival outcomes. Addressing these disparities is essential in achieving equitable oncology care. Artificial intelligence (AI) is revolutionizing oncology by leveraging advanced computational methods to [...] Read more.
Background: Social determinants of health (SDOH) are critical contributors to cancer disparities, influencing prevention, early detection, treatment access, and survival outcomes. Addressing these disparities is essential in achieving equitable oncology care. Artificial intelligence (AI) is revolutionizing oncology by leveraging advanced computational methods to address SDOH-driven disparities through predictive analytics, data integration, and precision medicine. Methods: This review synthesizes findings from systematic reviews and original research on AI applications in cancer-focused SDOH research. Key methodologies include machine learning (ML), natural language processing (NLP), deep learning-based medical imaging, and explainable AI (XAI). Special emphasis is placed on AI’s ability to analyze large-scale oncology datasets, including electronic health records (EHRs), geographic information systems (GIS), and real-world clinical trial data, to enhance cancer risk stratification, optimize screening programs, and improve resource allocation. Results: AI has demonstrated significant advancements in cancer diagnostics, treatment planning, and survival prediction by integrating SDOH data. AI-driven radiomics and histopathology have enhanced early detection, particularly in underserved populations. Predictive modeling has improved personalized oncology care, enabling stratification based on socioeconomic and environmental factors. However, challenges remain, including AI bias in screening, trial underrepresentation, and treatment recommendation disparities. Conclusions: AI holds substantial potential to reduce cancer disparities by integrating SDOH into risk prediction, screening, and treatment personalization. Ethical deployment, bias mitigation, and robust regulatory frameworks are essential in ensuring fairness in AI-driven oncology. Integrating AI into precision oncology and public health strategies can bridge cancer care gaps, enhance early detection, and improve treatment outcomes for vulnerable populations. Full article
(This article belongs to the Special Issue Innovations in Addressing Disparities in Cancer)
Show Figures

Figure 1

Back to TopTop